(Albany, US) DelveInsight launched a new report on Shigella Infections – Market Insights, Epidemiology, and Market Forecast-2030
DelveInsight’s “Shigella Infections – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Shigella Infections, historical and forecasted epidemiology as well as the Shigella Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The key facts of the report:“Shigella infections or Shigellosis causes approximately 450,000 cases of diarrhoea in the United States annually.”
Key benefits of the report:1. Shigella infections market report covers a descriptive overview and comprehensive insight of the Shigella infections epidemiology and Shigella infections market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)2. Shigella infections market report provides insights on the current and emerging therapies.3. Shigella infections market report provides a global historical and forecasted market covering drug outreach in 7 MM.4. Shigella infections market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Shigella infections market.
The key players in Shigella infections market are:
1. LimmaTech Biologics AG2. GlaxoSmithKline3. Immuron
The launch of the emerging therapies is expected to significantly impact Shigella infections treatment scenario in the upcoming years:-
Drugs covered:1. GSK3536852Aand others
To download a free report on Shigella infections, click here.
Table of contents1. Report Introduction2. Executive Summary3. SWOT analysis4. Shigellosis Patient Share (%) Overview at a Glance5. Shigella infections Market Overview at a Glance6. Shigella infections Disease Background and Overview7. Shigella infections Epidemiology and Patient Population8. Country-Specific Patient Population of Shigellosis8.1. United States8.2. EU58.2.1. Germany8.2.2. France8.2.3. Italy8.2.4. Spain8.2.5. United Kingdom8.3. Japan9. Current Shigella infections Treatment and Medical Practices10. Unmet Needs11. Shigella infections Emerging Therapies12. Key Cross Competition12.1. GSK3536852A: GlaxoSmithKline13. Shigellosis Market Outlook14. Country-Wise Market Analysis (2017–2030)14.1. United States Market Size14.2. Germany Market Size14.3. France Market Size14.4. Italy Market Size14.5. Spain Market Size14.6. United Kingdom Market Size14.7. Japan Market Size15. Market Access and Reimbursement of Therapies16. Market drivers17. Market barriers18. Appendix19. Report Methodology20. DelveInsight Capabilities21. Disclaimer22. About DelveInsight
Related reports:
Shigella Infections – Epidemiology Forecast to 2030
Shigella Infections Pipeline Insight, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/